ID H0530

Health benefit plans must ensure copayments, deductibles, or coinsurance for oral anticancer medications do not exceed those for injected or IV-administered anticancer medications

Alternative compliance option caps out-of-pocket costs for oral anticancer medications at $250 per 30-day supply

Insurers cannot circumvent requirements by increasing cost-sharing amounts for anticancer medications or reclassifying benefits

Health benefit plans are not required to classify anticancer medications as a medical benefit rather than a pharmacy benefit

Effective date: July 1, 2026, with emergency declaration